MC-Gly-Gly-Phe-Boc
Product Specifications
UNSPSC Description
MC-Gly-Gly-Phe-Boc is involved in the synthesis of antibody-drug conjugates (ADCs) to Trastuzumab (HY-P9907). MC-Gly-Gly-Phe-Boc can participate in cancer research[1].
Target Antigen
ADC Linker
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mc-gly-gly-phe-boc.html
Solubility
10 mM in DMSO
Smiles
O=C(C=CC1=O)N1CCCCCC(NCC(NCC(N[C@H](C(OC(C)(C)C)=O)CC2=CC=CC=C2)=O)=O)=O
Molecular Weight
528.60
References & Citations
[1]Naito Hiroyuki, et al. Anti-human HER2 antibody drug conjugates with excellent safety and therapeutic antitumor effect: World Intellectual Property Organization, WO2015115091 A1 2015-08-06. |[2]Naito Hiroyuki, et al. Anti-human HER2 antibody drug conjugates with excellent safety and therapeutic antitumor effect: World Intellectual Property Organization, WO2015115091 A1 2015-08-06.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-148773/MC-Gly-Gly-Phe-Boc-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-148773/
Clinical Information
No Development Reported
CAS Number
1599440-14-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1388008-01 0.02 mg (E-Coli)
Recombinant Shewanella frigidimarina Diaminopimelate epimerase (dapF)
Ask
View Details 
MBS1388008-02 0.02 mg (Yeast)
Recombinant Shewanella frigidimarina Diaminopimelate epimerase (dapF)
Ask
View Details MBS1388008-03 0.1 mg (E-Coli)
Recombinant Shewanella frigidimarina Diaminopimelate epimerase (dapF)
Ask
View Details MBS1388008-04 0.1 mg (Yeast)
Recombinant Shewanella frigidimarina Diaminopimelate epimerase (dapF)
Ask
View Details